Literature DB >> 6197660

Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors.

K Koshiya, T Kato.   

Abstract

Effects of acutely administered drugs acting on dopamine, muscarine or GABA receptors on the substance P content in rat substantia nigra were examined. Systemic injection of apomorphine caused a significant reduction in the nigral substance P content. This effect was found to be partially inhibited by atropine pretreatment. Haloperidol completely abolished the effect of apomorphine, while sulpiride did not. When administered alone, haloperidol, sulpiride or atropine had no effect on the nigral substance P content. Oxotremorine, the muscarine receptor agonist, reduced substance P content in th rostral half of the substantia nigra. Reduction in the nigral substance P content was also induced by treatment with the GABA receptor antagonist picrotoxin. On the other hand, diazepam increased the substance P content. These results suggest that the striatonigral substance P neurons could be regulated by dopaminergic, cholinergic and GABAergic systems, and that the dopaminergic influence on the substantia P neurons may be mediated, at least in part, by the cholinergic system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197660     DOI: 10.1007/bf00503899

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Synaptic mechanisms in the substantia nigra.

Authors:  A Dray; D W Straughan
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

Review 2.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

3.  Substance P in the substantia nigra.

Authors:  J Davies; A Dray
Journal:  Brain Res       Date:  1976-05-14       Impact factor: 3.252

4.  Brain GABA, dopamine and acetylcholine interactions. 1. Studies with oxotremorine.

Authors:  M Pérez de la Mora; K Fuxe
Journal:  Brain Res       Date:  1977-10-21       Impact factor: 3.252

5.  Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.

Authors:  R Michelot; V Leviel; M F Giorguieff-Chesselet; A Chéramy; J Glowinski
Journal:  Life Sci       Date:  1979-02-19       Impact factor: 5.037

6.  Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.

Authors:  G R Hanson; L Alphs; W Wolf; R Levine; W Lovenberg
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

7.  Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.

Authors:  P Janicki; A Lypko; A Szczudlik; J Libich
Journal:  Pol J Pharmacol Pharm       Date:  1981

8.  The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain.

Authors:  A S Eison; M S Eison; S D Iversen
Journal:  Brain Res       Date:  1982-04-22       Impact factor: 3.252

9.  Effects of substance P injected into the substantia nigra.

Authors:  T A James; M S Starr
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

10.  D-Amphetamine reduces striatal substance P concentrations by presynaptic release of dopamine.

Authors:  D J Pettibone; R J Wurtman
Journal:  Brain Res       Date:  1980-03-31       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.